This inventor holds 1 USPTO granted patent. Top assignee: Sandoz Ag. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Anandkrishna Laxmikant Kulkanri
Introduction
Anandkrishna Laxmikant Kulkanri is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the pharmaceutical field, particularly with his innovative formulations. His work exemplifies the intersection of science and technology, leading to advancements that can improve patient care.
Latest Patents
Anandkrishna holds a patent for an elagolix formulation. This pharmaceutical formulation includes elagolix sodium, magnesium oxide, and at least one disintegrating agent, such as crospovidone, croscarmellose sodium, sodium starch glycolate, and pregelatinized starch. The patent also describes a tablet that features a core formed from this pharmaceutical formulation. The elagolix sodium tablets demonstrate improved dissolution rates when tested, such as in the Tablet Sink Time test. Additionally, these tablets exhibit enhanced storage stability, showing a reduction in degradation products during storage. Anandkrishna's patent represents a significant advancement in the formulation of pharmaceutical products.
Career Highlights
Anandkrishna is currently associated with Sandoz AG, a global leader in generic pharmaceuticals and biosimilars. His role at Sandoz AG allows him to contribute to the development of innovative solutions in the healthcare sector. His expertise in pharmaceutical formulations has been instrumental in driving forward the company's mission to provide high-quality medicines.
Collaborations
Anandkrishna has collaborated with talented professionals such as Vivek Battu and Akash Vijay Lingayat. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Anandkrishna Laxmikant Kulkanri's contributions to the pharmaceutical industry through his innovative elagolix formulation highlight his role as a significant inventor. His work not only advances pharmaceutical science but also enhances the quality of healthcare solutions available to patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
